CCL2 and breast cancer: Although we previously observed significant increases in macrophages early in tumor development in glands humanized with SVF/CCL2 stromal cells [18], no differences were observed within the SVF/EV and SVF/CCL2 mammary tumors for F4/80 + macrophages at end-stage (p = 0.5, Figure 1D).